Morgan Lewis

Related Events

06/30/13-07/03/13 American Health Lawyer’s Association Annual Meeting
W. Reece Hirsch and Andrew Ruskin, speakers
View all events

Related News

01/09/07 Andrew Ruskin Brings His Healthcare Regulatory Practice to Morgan Lewis
Morgan Lewis is pleased to announce that Andrew Ruskin has brought his healthcare regulatory practice to the firm. Mr. Ruskin counsels clients on the full array of regulatory issues affecting the healthcare industry.
View all news
View Printable List

Andrew Ruskin

Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5960
Fax: 202.739.3001

63 Publications Found
next page show all
page 1 of 3
Date Title Publication
03/19/1303/19/13 Differential Charging to medicare and Self-Pay and Commercial Payors, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore

pdf View Presentation
Speech
02/28/1302/28/13 Analyzing the Current and Possible Future Part B Reimbursement Landscape

pdf View Presentation
Speech
01/28/1301/28/13 Incentivizing Quality Improvement – Better to Appeal to Professional Pride or Pocketbook?

pdf View Presentation
Speech
01/16/1301/16/13 Minimizing FCA Liability Attaching to Price Reporting when Making Reasonable Assumptions, presented at the American Conference Institute’s 10th National Rx Drug Pricing Boot Camp

pdf View Presentation
Speech
09/12/1209/12/12 Recent Part D Changes – Implications for Pharmaceutical Manufacturers, presented for FX Conferences

pdf View Presentation
Speech
07/20/1207/20/12 Massachusetts Amends Anti-Kickback Law

pdf View LawFlash
Life Sciences and Healthcare LawFlash
06/25/12June 2012 Manufacturers Affected by Recent Medicare Part D Rule, LMG Life Sciences 2012

pdf View Article
Article
06/05/122012 Out of Bounds: CMS Proposed Rule for AMP Under Medicaid, PLC's Multi-Jurisdictional Guide 2012: Life Sciences

pdf View Article
Article
05/22/1205/22/12 Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges, presented at the AHLA/FDLI's Intersecting Worlds of Drug, Device, Biologics and Health Law

pdf View Presentation
pdf View Supplement
Speech
04/18/1204/18/12 Manufacturers Affected by Recent Medicare Part D Rule

pdf View LawFlash
Life Sciences and Healthcare LawFlash
03/29/1203/29/12 HACs, Readmissions and VBP: Hospital Strategies for Turning Lemons into Lemonade, presented at the Institute on Medicare and Medicaid Payment Issues, Baltimore, MD

pdf View Presentation
Speech
02/06/1202/06/12 CMS Proposes Major Changes to AMP Rule

pdf View LawFlash
Life Sciences and Healthcare LawFlash
11/16/1111/16/11 Avoiding Anti-Kickback Challenges Related to Pricing and Contracting, presented at the 8th National Rx Drug Pricing Boot Camp, New York

pdf View Presentation
Speech
03/01/1103/01/11 Medicare Part D and the Coverage Gap Discount Program, presented at ACI’s 9th Annual Advanced Forum on Government Regulation of Prescription Drug Pricing, New York

pdf View Presentation
Speech
11/18/1011/18/10 Understanding the Interrealtionship of Pricing Methodologies and How One Price May Affect Another, presented at ACI's Prescription Drug Pricing Boot Camp

pdf View Presentation
Speech
11/15/1011/15/10 USP to Update Medicare Model Guidelines

pdf View LawFlash
FDA and Healthcare LawFlash
07/06/1007/06/10 Price Reporting and Governmental Rebate Issues Arising from the Healthcare Reform Law—an Early Assessment

pdf View LawFlash
Washington Government Relations and Public Policy LawFlash
04/13/1004/13/10 Healthcare Reform Law: Issues Affecting Hospitals and Health Systems

pdf View LawFlash
Washington Government Relations and Public Policy LawFlash
01/23/0901/23/09 CMS Regulation Addresses Protected Drug Categories and Classes

pdf View LawFlash
FDA and Healthcare LawFlash
06/29/0806/29/08 Off-Label Use of Drugs and Devices, presented at the American Health Lawyers Association's 2008 In-House Counsel Program & Annual Meeting, San Francisco


Speech
11/15/0711/15/07 Implications of CMS Clinical Research Policy, presented as a webinar for The Center for Business Intelligence


Speech
07/18/0707/18/07 CMS Proposes Changes to Its Policies Governing Off-Label Uses of Anticancer Drugs and Biologicals

pdf View LawFlash
FDA and Healthcare LawFlash
03/22/0703/22/07 The Patient's Nose Under the Tent: The Impact on Hospitals of State and Federal Healthcare Transparency Initiatives, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore


Speech
03/21/0703/21/07 2006: The RAP Practice Group's Year in Review, presented at the American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues, Baltimore


Speech
03/02/0703/02/07 Potential Challenges to Pricing of Biotech Products: Medicare/Medicaid and Related Pricing Developments, presented at the 2007 BIO General Counsels' Committee Meeting

pdf View Presentation
Speech
next page show all
page 1 of 3